Publication | Open Access

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

MedicineGemcitabine Versus GemcitabineMetronomic TherapyGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer